Radial Health develops the clinical infrastructure, reimbursement tools, and an AI-guided decision support platform to support delivery of Brain Medicine treatments, including non-invasive therapies such as Deep TMS. The company operates as a management services organization for a network of Brain Medicine clinics and is building a national platform for advanced mental health care. Radial is using capital from its Series A syndicate to expand its clinical footprint, strengthen its technology platform, and increase patient access to evidence-based Brain Medicine treatments. The financing is also intended to support Radial's exploration of M&A opportunities. Investors in the company’s recent financing include BrainsWay, General Catalyst, Floating Point Capital, Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and Diede van Lamoen.

Total raised

$53M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2026